AI Revolutionizes Glaucoma Care

Imagine walking into a supermarket, train station, or shopping mall and having your eyes screened for glaucoma within seconds - no appointment needed. With the AI-based Glaucoma Screening (AI-GS) network, this vision could soon become a reality.

Glaucoma is the leading cause of irreversible blindness in Japan and worldwide. Early detection is critical, as the disease progresses silently, slowly constricting one's peripheral field of vision. Patients often don't notice this loss of vision at first, which means that extensive and irreversible damage can occur before a patient even thinks about booking a doctor's appointment. As a result, many cases remain undiagnosed due to the limited availability of ophthalmologists and the challenges of conducting mass screenings, particularly in resource-limited regions.

"This is why we developed a new, quick, portable testing method. It analyzes multiple key indicators of glaucoma, integrates the findings, and determines the presence of the disease with unprecedented precision," explains Professor Toru Nakazawa (Tohoku University).

The AI-GS was developed by a research team led by Nakazawa and Associate Professor Parmanand Sharma at the Graduate School of Medicine (Tohoku University).

The AI-GS network was tested on a dataset of 8,000 fundus images of the back of the eye (where glaucomatous damage occurs), achieving an impressive 93.52% sensitivity at 95% specificity - a level comparable to expert ophthalmologists. Unlike traditional AI models, this system excels at detecting early-stage glaucoma, even in cases where fundus abnormalities are subtle and difficult to recognize.

A major challenge in AI-driven healthcare is its lack of interpretability - the so-called "black box" problem where it's unclear what steps the AI made to come to a conclusion. AI-GS solves this by providing numerical values for each diagnostic feature, allowing ophthalmologists to understand and verify its decision-making process. This transparency enhances trust and facilitates seamless integration into clinical practice.

Another important aspect of making practical implementation as simple as possible was size. At just 110 MB, the AI-GS network is designed for portability and efficiency. It requires minimal computational power and delivers diagnostic results in under a second.

"AI-GS brings expert-level glaucoma screening to your pocket, complementing specialist evaluations," says Associate Professor Parmanand Sharma (Tohoku University), "It can be run on a mobile device and used in all sorts of public places because of its portability. You can run screenings at train stations or even remote regions that otherwise have limited access to ophthalmologists."

"This AI technology bridges a critical gap in glaucoma detection by making specialist-level diagnostics accessible to underserved communities," remarks Professor Nakazawa, "By enabling early detection on a large scale, we have the potential to prevent blindness for millions worldwide."

With its high accuracy, AI explainability, and lightweight design, the AI-GS network represents a major breakthrough in AI-driven ophthalmology, bringing glaucoma screening out of hospitals and into everyday life. Large-scale implementation of this system could revolutionize glaucoma care, ensuring that no patient is left undiagnosed due to a lack of access to specialists.

Sharma P, Takahashi N, Ninomiya T, Sato M, Miya T, Tsuda S, Nakazawa T.
A hybrid multi model artificial intelligence approach for glaucoma screening using fundus images.
NPJ Digit Med. 2025 Feb 27;8(1):130. doi: 10.1038/s41746-025-01473-w

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...